Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study
about
sameAs
Acute coronary disease Athero-Inflammation: Therapeutic approachThe antithrombotic profile of aspirin. Aspirin resistance, or simply failure?Antiplatelet therapy from clinical trials to clinical practice.Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasisAnithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapyCardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibArrhythmogenic consequences of intracellular calcium waves.Evaluation of the effect of andrographolide on atherosclerotic rabbits induced by Porphyromonas gingivalisMeloxicam: a reappraisal of pharmacokinetics, efficacy and safety.The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.Relationship between cyclooxygenase-2 inhibition and thrombogenesis.Cardiovascular effects of selective cyclooxygenase-2 inhibitors.Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation.Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemiaBlocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.Celecoxib for the treatment of atherosclerosis.Cardiovascular safety of celecoxib on top of dual antiplatelet therapy.Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.Spatially discordant alternans in cardiomyocyte monolayers.Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study.The chicken or the egg? Voltage and calcium dynamics in the heart.
P2860
Q24793068-F0666183-ED9E-4715-A0B3-6D68EC72A004Q24794673-61C39BB3-58EE-4B90-9080-0D11200B9CC1Q28176354-1A65BE24-EFF3-4AB6-B210-F2871A2F5683Q28196701-987FE591-53C3-4D31-8327-6EBBAE876E58Q28220433-E3A91806-DF4A-48D6-8103-B62C1454D67FQ28222097-57227D2F-B4FB-4A64-9C98-84079EA5F7DDQ30490734-5FAF89AF-518C-47FF-9133-2074D5C63456Q34120640-092B63EC-A5F5-4B2E-B7C8-AEE4FD52FDBEQ34561392-E0253426-4940-450F-A5D5-A8DBE595CE83Q34636574-47443309-6315-4424-8FAA-BB340A3063AEQ35750211-42A8DC27-35E0-40BC-8F60-726229A450DDQ35777371-872B47B1-11D1-40BE-AA6B-A2C5B0578128Q36304331-60AA06C8-AC90-4028-A445-24F52674C2DDQ36816861-A2E855E8-D6D5-4E7D-BFB5-B4397732087CQ37152580-C3D38BC2-D42D-4826-9DAE-40E2C781B7C6Q38008700-3A26FB6F-7D93-45C9-8B63-EB5A3DB5F10BQ38759585-23262342-8279-477D-81AC-A96E6DE937C9Q42701083-F9A82DDE-7527-46BF-B26B-39C1F4001CFAQ43234063-6ACDBA5B-D187-4ECF-9FD0-F7F5B5E066A6Q46788961-F02ED8E6-6C64-4C0C-9E29-D79D3F9E7799Q51794991-455912A6-AC41-47F4-981A-4B9E699F0AD0Q51909508-B929E93B-08D8-459F-AEFE-B4C9685B6250
P2860
Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@ast
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@en
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@nl
type
label
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@ast
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@en
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@nl
prefLabel
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@ast
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@en
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@nl
P2093
P1433
P1476
Efficacy assessment of meloxic ...... reatment-2 (NUT-2) pilot study
@en
P2093
Claudio Gonzalez
Fatima Del Rio
Hector L Luciardi
Juan Muntaner
Raul Altman
Ruben Lopez
Sofia G Berman
P356
10.1161/01.CIR.0000021599.56755.A1
P407
P577
2002-07-09T00:00:00Z